missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ ABCB8 Polyclonal Antibody
Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA5122301
This item is not returnable.
View return policy
Description
ABCB8 Polyclonal Antibody for Western Blot, IHC (P)
This nuclear gene encodes a multi-pass membrane protein that is targeted to the mitochondrial inner membrane. The encoded protein is an ATP-dependent transporter that may mediate the passage of organic and inorganic molecules out of the mitochondria. Loss of function of the related gene in mouse results in a disruption of iron homeostasis between the mitochondria and cytosol. Alternative splicing results in multiple transcript variants.
Specifications
| ABCB8 | |
| Polyclonal | |
| Unconjugated | |
| ABCB8 | |
| 4833412N02Rik; AA409895; ABC transporter 8; Abcb8; ATP binding cassette subfamily B member 8; ATP-binding cassette sub-family B member 8, mitochondrial; ATP-binding cassette, subfamily B (MDR/TAP), member 8; ATP-binding cassette, sub-family B (MDR/TAP), member 8; ATP-binding cassette, sub-family B, member 8; EST328128; hypothetical protein LOC548340; MABC1; M-ABC1; mitochondrial ABC protein; mitochondrial ATP-binding cassette 1; mitochondrial potassium channel ATP-binding subunit; mitochondrial sulfonylurea-receptor; MITOSUR; zgc:113037 | |
| Rabbit | |
| Antigen affinity chromatography, Protein A | |
| RUO | |
| 11194 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Immunohistochemistry (Paraffin), Western Blot, Western Blot | |
| 0.5 mg/mL | |
| PBS with 50% glycerol and 0.05% ProClin 300; pH 7.4 | |
| Q9NUT2 | |
| ABCB8 | |
| Recombinant protein ATP Binding Cassette Transporter B8. The antigen corresponds to amino acid range 472-735 of the target protein. | |
| 20 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction